Bacterial endocarditis of tricospidal valve prosthesis in a patient with Lupus: a case report

Vol 1, 2023 - 164978
Poster (On site Format)
Favorite this paper
How to cite this paper?
Abstract

Introduction: Infective endocarditis is an infection of the cardiac endothelial tissue that can be acquired in the community or in a hospital environment. Staphylococcus aureus is the most common agent, and the treatment is complex because of the vascularization of the vegetation. Some exams are performed to aid diagnosis, including collection of blood cultures and echocardiography, so that the diagnosis is confirmed when the patient has the modified Duke criteria. The basis of treatment is antibiotic therapy, guided by blood cultures, and may have surgical indication in severe cases. Objective: To report the case of systemic lupus erythematosus patient with bacterial endocarditis secondary to an intravascular device, who underwent surgery to place a tricuspid valve prosthesis and, in less than six months, presented a new infectious condition in the valve, evolving with complications and later, death; alerting to the predictive factors of poor prognosis in these cases. Method: Data for this case report were collected from medical records, test results and literature review. Results: Female patient, caucasian, 41 years old, with systemic lupus erythematosus, using immunosuppressive medication, in addition to a history of tricuspid valve replacement due to endocarditis in 2022 correlated to the use of a portocath device implanted in 2021 due to osteomyelitis caused by a car accident . She sought medical care due to constitutional symptoms and odynophagia, and new tests were performed, the results showed active lupus (manifested by thrombocytopenia) and a transthoracic echocardiogram showed vegetation in the biological tricuspid valve measuring 27 mm³. Therefore, hospitalization was chosen for antibiotic therapy and intravenous immunoglobulin, since high-dose corticosteroid therapy was contraindicated due to infection. However, during the hospitalization, the patient developed dyspnea, hemodynamic instability and cyanosis of the extremities, with the hypothesis of septic embolization being suggested. However, we were faced with the impossibility of anticoagulation due to severe thrombocytopenia, refractory to the implemented medications (corticosteroids and immunoglobulin), as well as a new surgical approach for the same reason. The patient used intravenous immunoglobulin for five days, in addition to antibiotic therapy guided by blood culture, however, the condition did not improve, evolving to death. Conclusion: Infective endocarditis has a high mortality rate even with early diagnosis and treatment. The presence of factors such as: comorbidities, use of immunosuppressive medication, early valve reinfection, large vegetation, growth despite antibiotic therapy and embolization, predicted a poor prognosis in this case, culminating in death as the outcome.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Centro Universitário Padre Albino (UNIFIPA)
Track
  • 1. Management of diseases and immune response: inflammatory, infectious, non-infectious, autoimmune and lifestyle diseases
Keywords
Infective Endocarditis; Systemic Lupus Erythematosus; Reinfection